BlackRock Japan’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
– Sell
-353
Closed -$6K – 1316
2016
Q3
$6K Sell
353
-280
-44% -$4.3K ﹤0.01% 1243
2016
Q2
$9K Sell
633
-384
-38% -$5.85K ﹤0.01% 1289
2016
Q1
$17K Hold
1,017
– – ﹤0.01% 1203
2015
Q4
$23K Hold
1,017
– – ﹤0.01% 1145
2015
Q3
$22K Buy
+1,017
New +$25.4K ﹤0.01% 1082
2014
Q1
– Sell
-1,204
Closed -$22K – 1394
2013
Q4
$22K Sell
1,204
-1,474
-55% -$21.4K ﹤0.01% 1216
2013
Q3
$29K Buy
+2,678
New +$26.4K ﹤0.01% 1188

Other funds holding ATRC

BlackRock Japan's ATRC Position: Q4 2016 in Review

BlackRock Japan sold out of AtriCure (ATRC) in Q4 2016, closing a stake of 353 shares — an estimated $6K sold.

BlackRock Japan first reported a position in ATRC in Q3 2013 and held it in 7 quarters. The position peaked at $29K in Q3 2013. 100 funds tracked by Wall St. Rank hold ATRC as of Q4 2016.

  • BlackRock Japan reported no remaining AtriCure position as of Q4 2016 after selling out during the quarter.
  • BlackRock Japan sold 353 AtriCure shares in Q4 2016, an estimated $6K.
  • BlackRock Japan first reported a position in AtriCure in Q3 2013 and held it in 7 quarters.
  • BlackRock Japan's AtriCure position peaked at $29K in Q3 2013.
  • 100 funds tracked by Wall St. Rank held AtriCure as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.